The effects of cannabidiol (CBD) on cognition and symptoms in outpatients with chronic schizophrenia a randomized placebo controlled trial.

Saved in:
Bibliographic Details
Title: The effects of cannabidiol (CBD) on cognition and symptoms in outpatients with chronic schizophrenia a randomized placebo controlled trial.
Authors: Boggs, Douglas L.1,2, Surti, Toral1,2,3, Gupta, Aarti1,2,3, Gupta, Swapnil1,2,3, Niciu, Mark4, Pittman, Brian2,3, Schnakenberg Martin, Ashley M.1,2,3, Thurnauer, Halle1,2,3, Davies, Andrew5, D’Souza, Deepak C.1,2,3, Ranganathan, Mohini1,2,3 Mohini.Ranganathan@yale.edu
Source: Psychopharmacology. Jul2018, Vol. 235 Issue 7, p1923-1932.
Database: SPORTDiscus with Full Text
Full text is not displayed to guests.
Description
ISSN:00333158
DOI:10.1007/s00213-018-4885-9